Literature DB >> 19807744

Primary congenital glaucoma caused by the homozygous F261L CYP1B1 mutation and paternal isodisomy of chromosome 2.

M-P López-Garrido1, E Campos-Mollo, M-A Harto, J Escribano.   

Abstract

Primary congenital glaucoma (PCG), a rare, severe and blinding disease, usually results from mutations in the CYP1B1 gene located in chromosome 2p22.2. Uniparental isodisomy (UPID) is also a rare condition in which a diploid offspring carries two identical copies of a single parental chromosome. By DNA sequence analysis, we found that a proband (female newborn) affected by PCG was homozygous for the null-allele F261L of the CYP1B1 gene. Her father was a heterozygous carrier for this mutation, and unexpectedly her mother carried only the G168D mutation in the heterozygous state. Segregation analysis of eight microsatellite markers which spanned the two arms of chromosome 2 was consistent with paternal isodisomy for this chromosome in the proband. To the best of our knowledge, this is the first reported case of UPID resulting in PCG and the fifth reported case of paternal UPID for chromosome 2. In addition, the absence of a clinical phenotype other than PCG confirms previous observations of there being no paternally imprinted genes in chromosome 2 that have major phenotypic effects. These results, along with previous reports, also suggest that UPID may play a relevant role in recessive diseases linked to chromosome 2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807744     DOI: 10.1111/j.1399-0004.2009.01242.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

Review 1.  Whole exome sequencing in a patient with uniparental disomy of chromosome 2 and a complex phenotype.

Authors:  H Carmichael; Y Shen; T T Nguyen; J N Hirschhorn; A Dauber
Journal:  Clin Genet       Date:  2012-12-20       Impact factor: 4.438

2.  Whole-exome sequencing analysis in a case of primary congenital glaucoma due to the partial uniparental isodisomy.

Authors:  Parisima Ghaffarian Zavarzadeh; Morteza Bonyadi; Zahra Abedi
Journal:  Genomics Inform       Date:  2022-09-30

Review 3.  Maternal uniparental isodisomy causing autosomal recessive GM1 gangliosidosis: a clinical report.

Authors:  Jessica E King; Amy Dexter; Inder Gadi; Val Zvereff; Meaghan Martin; Miriam Bloom; Adeline Vanderver; Amy Pizzino; Johanna L Schmidt
Journal:  J Genet Couns       Date:  2014-04-30       Impact factor: 2.537

4.  Functional and Structural Analyses of CYP1B1 Variants Linked to Congenital and Adult-Onset Glaucoma to Investigate the Molecular Basis of These Diseases.

Authors:  Antara Banerjee; Subhadip Chakraborty; Abhijit Chakraborty; Saikat Chakrabarti; Kunal Ray
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

5.  Goniodysgenesis variability and activity of CYP1B1 genotypes in primary congenital glaucoma.

Authors:  María T García-Antón; Juan J Salazar; Rosa de Hoz; Blanca Rojas; Ana I Ramírez; Alberto Triviño; José-Daniel Aroca-Aguilar; Julián García-Feijoo; Julio Escribano; José M Ramírez
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

6.  Primary congenital glaucoma due to paternal uniparental isodisomy of chromosome 2 and CYP1B1 deletion.

Authors:  Emmanuelle Souzeau; Andrew Dubowsky; Jonathan B Ruddle; Jamie E Craig
Journal:  Mol Genet Genomic Med       Date:  2019-06-28       Impact factor: 2.183

7.  Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population.

Authors:  Elena Millá; Begoña Mañé; Susana Duch; Imma Hernan; Emma Borràs; Ester Planas; Miguel de Sousa Dias; Miguel Carballo; María José Gamundi
Journal:  Mol Vis       Date:  2013-08-04       Impact factor: 2.367

Review 8.  Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma.

Authors:  Muneeb Faiq; Reetika Sharma; Rima Dada; Kuldeep Mohanty; Daman Saluja; Tanuj Dada
Journal:  J Curr Glaucoma Pract       Date:  2013-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.